Jeffrey Tyner

Physics and AstronomyEarth and Planetary SciencesEngineeringMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 24 papers. Top paper: “Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia”.

Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia

Proceedings of the National Academy of Sciences(2020)10.1073/pnas.1916206117

N/A

0DataRank · unranked

105 citations

Yoko Kosaka, Ted Laderas, Allie Maffit, Andy Kaempf, Lauren Brady +17 more

Discovery and characterization of targetable NTRK point mutations in hematologic neoplasms

Blood(2020)10.1182/blood.2019003691

N/A

0DataRank · unranked

40 citations

Kristin Qian, William H. Bisson, Kevin Watanabe‐Smith, Ariane Huang, Daniel Bottomly +7 more

Functional genomic analysis identifies drug targetable pathways in invasive and metastatic cutaneous squamous cell carcinoma

Molecular Case Studies(2020)10.1101/mcs.a005439

N/A

0DataRank · unranked

9 citations

Danielle McClanahan, James E. Jacobs, Sophia Jeng, Myles Vigoda, Aurora Blucher +13 more

UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models

UNC Libraries(2020)10.17615/wa7e-m156

N/A

0DataRank · unranked

0 citations

Jeffrey Tyner, Lauren S. Page, Alisa B. Lee‐Sherick, Douglas K. Graham, Madeline G. Huey +10 more

Monocytic Differentiation and AHR Signaling as Primary Nodes of BET Inhibitor Response in Acute Myeloid Leukemia

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-21-0012

N/A

0DataRank · unranked

35 citations

Tamilla Nechiporuk, Daniel Bottomly, Sophia Jeng, Shannon K. McWeeney, Andy Kaempf +4 more

Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia

npj Precision Oncology(2021)10.1038/s41698-021-00209-9

N/A

0DataRank · unranked

32 citations

Suleiman A. Khan, Mike J. Mason, Muhammad Ammad-ud-din, Swapnil Potdar, Disha Malani +12 more

TNK1 is a ubiquitin-binding and 14-3-3-regulated kinase that can be targeted to block tumor growth

Nature Communications(2021)10.1038/s41467-021-25622-3

N/A

0DataRank · unranked

32 citations

Christina M. Egbert, Julia E. Maxson, Adam Siddiqui, Logan Larsen, Kristina Kohler +23 more

A novel activating JAK1 mutation in chronic eosinophilic leukemia

Blood Advances(2021)10.1182/bloodadvances.2021004237

N/A

0DataRank · unranked

21 citations

Alisa Damnernsawad, Talent Theparee, David A. Sampson, Quinlan Morrow, Fei Yang +6 more

DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia

Genome Research(2021)10.1101/gr.269233.120

N/A

0DataRank · unranked

52 citations

Min Wang, Ada C Cleary, Yue-Zhong Wu, Anna Reister Schultz, Maximilian Schmutz +15 more

Integrative analysis of drug response and clinical outcome in acute myeloid leukemia

Cancer Cell(2022)10.1016/j.ccell.2022.07.002

N/A

0DataRank · unranked

373 citations

Nicola Long, Anna Reister Schultz, Stephen E. Kurtz, Cristina E. Tognon, Kara Johnson +89 more

Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B-cell receptor and Bcl-2 signaling networks in mantle cell lymphoma

Cell Death and Disease(2022)10.1038/s41419-022-04684-1

N/A

0DataRank · unranked

26 citations

Tingting Liu, Nur Bruss, Carly Roleder, Vi Lam, Xiaoguang Wang +9 more

The FLT3N701K mutation causes clinical AML resistance to gilteritinib and triggers TKI sensitivity switch to quizartinib

American Journal of Hematology(2023)10.1002/ajh.27096

N/A

0DataRank · unranked

9 citations

Janét Pittsenbarger, Vanessa E. Kennedy, Cheryl A.C. Peretz, Alexander E. Perl, Catherine C. Smith +4 more

Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia

Molecular Cancer Research(2023)10.1158/1541-7786.mcr-22-0745

N/A

0DataRank · unranked

8 citations

Brittany M. Curtiss, Daniel J. Coleman, Jake VanCampen, Garth Kong, Jommel Macaraeg +10 more

Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR

Journal of Ovarian Research(2023)10.1186/s13048-023-01160-y

N/A

0DataRank · unranked

8 citations

Jeffrey Tyner, Sigal Gery, Yueyuan Zheng, Liyan Li, Mohan Shankar Gopinatha Pillai +5 more

Immune cell proportions correlate with clinicogenomic features and ex vivo drug responses in acute myeloid leukemia

Frontiers in Oncology(2023)10.3389/fonc.2023.1192829

N/A

0DataRank · unranked

1 citations

Daniel Bottomly, William M. Yashar, Nicola Long, Matthew Viehdorfer, Shannon K. McWeeney +2 more

Ribosomal protein control of hematopoietic stem cell transformation through regulation of metabolism.

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.05.31.543132

N/A

0DataRank · unranked

4 citations

Dinesh Kumar Singh, Billy Truong, Michele Rhodes, Rachael Price, Susan Shinton +25 more

Computational modeling of methylation impact of AML drivers reveals new pathways and refines AML risk-stratification

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.05.17.541249

N/A

0DataRank · unranked

0 citations

Jeffrey Tyner, Emek Demir, Brian Druker, Paul T. Spellman, Burcu Gurun

Knowledge graphs facilitate prediction of drug response for acute myeloid leukemia

iScience(2024)10.1016/j.isci.2024.110755

N/A

0DataRank · unranked

6 citations

Yue Zhang, Jeffrey Tyner, Christopher J. Kemp, Ilya Shmulevich, Guangrong Qin

Transcriptional and phenotypic heterogeneity underpinning venetoclax resistance in AML

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.01.27.577579

N/A

0DataRank · unranked

10 citations

Natalia Baran, Yuefan Huang, Cassandra L. Ramage, Laurie Cooper, Shan He +7 more

In vivo Targeting MEK and TNK2/SRC pathways in PTPN11 driven leukemia

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.05.16.594555

N/A

0DataRank · unranked

0 citations

Karina Thiel-Klare, Jeffrey Tyner, Bill H. Chang

CDK4/6 inhibition overcomes venetoclax resistance mechanisms with enhanced combination activity in acute myeloid leukemia

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102526

N/A

0DataRank · unranked

1 citations

Jessica Gibbs, Kevin Watanabe‐Smith, Ariel H. Nguyen, Isabel Kenna, Karina Thiel-Klare +12 more

A Rapid Gene Expression Profiler Classifies AML Tumor Responsiveness to Standard Therapies

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.08.681215

N/A

0DataRank · unranked

0 citations

Christopher A. Eide, Andy Kaempf, Nicola Long, Alexandria Miller, Daniel Bottomly +8 more

m6a and NuRD complexes regulate monocytic differentiation and resistance to BCL2/BCL2L1 inhibitors in acute myeloid leukemia

Haematologica(2025)10.3324/haematol.2025.287972

N/A

0DataRank · unranked

0 citations

Karen Morris, Quinlan Morrow, Stephen E. Kurtz, Daniel Bottomly, Shannon K. McWeeney +5 more

Ribosomal protein control of hematopoietic stem cell transformation through regulation of metabolism

Cell Reports(2025)10.1016/j.celrep.2025.116688

N/A

0DataRank · unranked

0 citations

Dinesh Kumar Singh, Billy Truong, Michele Rhodes, Rachael Price, Susan A. Shinton +25 more